Dealing With a Suicidal Patient: Rethinking Psychiatric Drugs — Psychologist Mary Vieten, PhD, ABPP HD

26.12.2019
For more information, including links to the scientific evidence base for the statements in this video, as well as further resources: http://medicatingnormal.com/ Dr. Mary Vieten’s biography: http://www.warfighteradvance.org/mary-vieten.html Article on Mary Vieten, PhD, ABPP: https://bit.ly/2OSimWq Article in the American Journal of Psychiatry about SSRI-induced suicidality: https://www.baumhedlundlaw.com/10.pdf A large meta-analysis in BMJ finding increased SSRI use linked to suicidality: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549110/ New York Times article: lawsuit over SSRI-induced suicidality: https://www.nytimes.com/2017/09/11/well/mind/paxil-antidepressants-suicide.html FDA black box suicide warning for Paxil (paroxetine): https://bit.ly/2DYIlFu FDA black box suicide warning for Prozac (fluoxetine): https://bit.ly/2YPMzu1 Examples of SSRIs (a common type of antidepressant) include: sertraline (Zoloft), fluoxetine (Prozac, Sarafem), citalopram (Celexa), escitalopram (Lexapro), paroxetine (Paxil, Pexeva, Brisdelle), and fluvoxamine (Luvox). Medicating Normal on Facebook: https://www.facebook.com/pg/medicatingnormalfilm/ Medicating Normal on Twitter: https://twitter.com/medicatingnorm1?lang=en Donate: https://medicatingnormal.com/donate/ Note: This video does not constitute medical advice. Stopping psychiatric drugs, especially abruptly, can be dangerous, as withdrawal effects may be severe, disabling or even life-threatening. Music: http://www.bensound.com/royalty-free-music Video edited by Daniel Mackler

Похожие видео